FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved a supplemental application for diclofenac sodium from Edenbridge Pharmaceuticals LLC under the ANDA program. This action constitutes a supplemental…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dental Pain
• Dysmenorrhea
• Migraine
• Osteoarthritis
• Pain
• Rheumatoid Arthritis

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM)